Skip to main content
. Author manuscript; available in PMC: 2015 Aug 28.
Published in final edited form as: Am J Gastroenterol. 2014 Aug 26;109(10):1675–1683. doi: 10.1038/ajg.2014.223

Table 2. Non-malignant complications developing in the AIP and IgG4-SC cohort.

Non-malignant complications % Of 115 patients
Liver
 Cirrhosis and liver failure 5
 Liver transplant 0.9
Pancreas
 Exocrine insufficiency 53
 Endocrine insufficiency (diabetes) 37
Renal
 Impaired renal function—stage 2–4 CKD 12
Vascular
 Portal and splenic vein thrombosis 9

AIP, autoimmune pancreatitis; CKD, chronic kidney disease; IgG4-SC, IgG4-related sclerosing cholangitis.